Skip to content

Income Tax at other companies

Pfizer logo
PfizerPFE
$461M+344%
Amgen logo
AmgenAMGN
$265M+9.1%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$0
Celcuity logo
CelcuityCELC
$0
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$170K+963%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$839K-24.3%

Other financials

Income statement

See full
Revenue$10.3M-79.9%
Operating income-$19.7M-187%
Net income-$18.2M-178%
EPS (diluted)-$0.10-137%

Balance sheet

See full
Cash & equivalents$28.8M-39.4%
Total debt$2.9M-65.0%
Total equity$319.9M+1,177%
Total assets$359.4M+265%

Cash flow

See full
Operating cash flow-$25.5M-21.4%
CapEx--100%
Free cash flow-$25.5M-20.7%

Valuation

See full
Market cap$711.89M+94.8%
Enterprise value$685.92M+110%
P/S20×+17.6×

Profitability

See full
Operating margin-181.9%-206pp
Net margin-166.4%-195pp
FCF margin-225.6%-334pp

Returns & leverage

See full
Return on equity-34.3%
Debt / equity-0.3×
Current ratio10.4×+8.7×

Where this comes from

Reported directly by CytomX Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: CytomX Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CytomX Therapeutics's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CytomX Therapeutics's income tax?
CytomX Therapeutics (CTMX) reported income tax of $59K in Q1 2026.
How has CytomX Therapeutics's income tax changed year-over-year?
CytomX Therapeutics's income tax decreased by 4.8% year-over-year, from $62K to $59K.
What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.